{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:43:08Z","timestamp":1768585388892,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11897-025-00732-x","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T07:26:12Z","timestamp":1763623572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Natriuretic Peptides: Corin and Furin As Phenotype-Specific Biomarkers and Therapeutic Gatekeepers in Heart Failure"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8376-8225","authenticated-orcid":false,"given":"Dhruvil Vinaybhai","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9043-6482","authenticated-orcid":false,"given":"Sanket","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9225-4108","authenticated-orcid":false,"given":"Sankalp","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karanrajsinh","family":"Raol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"4","key":"732_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcae110","volume":"11","author":"QF Chen","year":"2025","unstructured":"Chen QF, Chen L, Katsouras CS, et al. Global burden of heart failure and its underlying causes in 204 countries and territories, 1990\u20132021. Eur Heart J Qual Care Clin Outcomes. 2025;qcae110. https:\/\/doi.org\/10.1093\/ehjqcco\/qcae110.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"732_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.21037\/amj.2020.03.03","volume":"5","author":"G Lippi","year":"2020","unstructured":"Lippi G, Sanchis-Gomar F. Global epidemiology and future trends of heart failure. AME Med J. 2020;5:15\u201315. https:\/\/doi.org\/10.21037\/amj.2020.03.03.","journal-title":"AME Med J"},{"issue":"1","key":"732_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","volume":"31","author":"B Bozkurt","year":"2025","unstructured":"Bozkurt B, Ahmad T, Alexander K, et al. HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America. J Card Fail. 2025;31(1):66\u2013116. https:\/\/doi.org\/10.1016\/j.cardfail.2024.07.001.","journal-title":"J Card Fail"},{"issue":"10","key":"732_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","volume":"21","author":"MS Khan","year":"2024","unstructured":"Khan MS, Shahid I, Bennis A, Rakisheva A, Metra M, Butler J. Global epidemiology of heart failure. Nat Rev Cardiol. 2024;21(10):717\u201334. https:\/\/doi.org\/10.1038\/s41569-024-01046-6.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"732_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.15420\/cfr.2016:4:2","volume":"2","author":"NS Lee","year":"2016","unstructured":"Lee NS, Division of Cardiovascular Medicine, University of California, San Diego, La Jolla, CA, USA, Daniels LB, Division of Cardiovascular Medicine, University of California, San Diego, La Jolla, CA, USA. Current understanding of the compensatory actions of cardiac natriuretic peptides in cardiac failure: a clinical perspective. Card Fail Rev. 2016;2(1):14. https:\/\/doi.org\/10.15420\/cfr.2016:4:2.","journal-title":"Card Fail Rev"},{"issue":"8","key":"732_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4103\/2230-8210.86978","volume":"15","author":"K Pandit","year":"2011","unstructured":"Pandit K, Mukhopadhyay P, Ghosh S, Chowdhury S. Natriuretic peptides: diagnostic and therapeutic use. Indian J Endocrinol Metab. 2011;15(8):345. https:\/\/doi.org\/10.4103\/2230-8210.86978.","journal-title":"Indian J Endocrinol Metab"},{"key":"732_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107863","volume":"227","author":"K Kuwahara","year":"2021","unstructured":"Kuwahara K. The natriuretic peptide system in heart failure: diagnostic and therapeutic implications. Pharmacol Ther. 2021;227:107863. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107863.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"732_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1042\/CS20150469","volume":"130","author":"M Volpe","year":"2015","unstructured":"Volpe M, Carnovali M, Mastromarino V. The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clin Sci. 2015;130(2):57\u201377. https:\/\/doi.org\/10.1042\/CS20150469.","journal-title":"Clin Sci"},{"issue":"1","key":"732_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.59249\/NCST6937","volume":"96","author":"M Samad","year":"2023","unstructured":"Samad M, Malempati S, Restini CBA. Natriuretic peptides as biomarkers: narrative review andconsiderations in cardiovascular and respiratory dysfunctions. Yale J Biol Med. 2023;96(1):137\u201349. https:\/\/doi.org\/10.59249\/NCST6937.","journal-title":"Yale J Biol Med"},{"issue":"1","key":"732_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.29245\/2578-3009\/2023\/1.1245","volume":"7","author":"JW Lee","year":"2023","unstructured":"Lee JW, Aw D. Natriuretic peptides in clinical practice: a current review. J Immunol Sci. 2023;7(1):28\u201334. https:\/\/doi.org\/10.29245\/2578-3009\/2023\/1.1245.","journal-title":"J Immunol Sci"},{"key":"732_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3389\/fphys.2018.00692","volume":"9","author":"S Fu","year":"2018","unstructured":"Fu S, Ping P, Zhu Q, Ye P, Luo L. Brain natriuretic peptide and its biochemical, analytical, and clinical issues in heart failure: a narrative review. Front Physiol. 2018;9:692. https:\/\/doi.org\/10.3389\/fphys.2018.00692.","journal-title":"Front Physiol"},{"issue":"2","key":"732_CR12","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1152\/ajpregu.00233.2012","volume":"304","author":"T Ichiki","year":"2013","unstructured":"Ichiki T, Boerrigter G, Huntley BK, et al. Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis. Am J Physiol Regul Integr Comp Physiol. 2013;304(2):R102\u20139. https:\/\/doi.org\/10.1152\/ajpregu.00233.2012.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"732_CR13","doi-asserted-by":"publisher","first-page":"1120487","DOI":"10.3389\/fcvm.2023.1120487","volume":"10","author":"IP Gladysheva","year":"2023","unstructured":"Gladysheva IP, Sullivan RD, Reed GL. Falling Corin and ANP activity levels accelerate development of heart failure and cardiac fibrosis. Front Cardiovasc Med. 2023;10:1120487. https:\/\/doi.org\/10.3389\/fcvm.2023.1120487.","journal-title":"Front Cardiovasc Med"},{"issue":"3\u20134","key":"732_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.cca.2011.10.032","volume":"413","author":"N Dong","year":"2012","unstructured":"Dong N, Chen S, Wang W, Zhou Y, Wu Q. Corin in clinical laboratory diagnostics. Clin Chim Acta. 2012;413(3\u20134):378\u201383. https:\/\/doi.org\/10.1016\/j.cca.2011.10.032.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"732_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biology11050717","volume":"11","author":"X Zhang","year":"2022","unstructured":"Zhang X, Gu X, Zhang Y, Dong N, Wu Q. Corin: a key mediator in sodium homeostasis, vascular remodeling, and heart failure. Biology. 2022;11(5):717. https:\/\/doi.org\/10.3390\/biology11050717.","journal-title":"Biology"},{"issue":"10","key":"732_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2021.102198","volume":"50","author":"A Ohwaki","year":"2021","unstructured":"Ohwaki A, Nishizawa H, Kato A, et al. Altered serum soluble furin and prorenin receptor levels in pregnancies with pre-eclampsia and fetal growth restriction. J Gynecol Obstet Hum Reprod. 2021;50(10):102198. https:\/\/doi.org\/10.1016\/j.jogoh.2021.102198.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"5","key":"732_CR17","doi-asserted-by":"publisher","first-page":"H1687","DOI":"10.1152\/ajpheart.00399.2010","volume":"299","author":"S Chen","year":"2010","unstructured":"Chen S, Sen S, Young D, Wang W, Moravec CS, Wu Q. Protease Corin expression and activity in failing hearts. Am J Physiol-Heart Circ Physiol. 2010;299(5):H1687\u201392. https:\/\/doi.org\/10.1152\/ajpheart.00399.2010.","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"2","key":"732_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCHEARTFAILURE.109.903849","volume":"3","author":"N Dong","year":"2010","unstructured":"Dong N, Chen S, Yang J, et al. Plasma soluble Corin in patients with heart failure. Circ Heart Fail. 2010;3(2):207\u201311. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.903849.","journal-title":"Circ Heart Fail"},{"issue":"2","key":"732_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1161\/CIRCHEARTFAILURE.109.895581","volume":"4","author":"UN Ibebuogu","year":"2011","unstructured":"Ibebuogu UN, Gladysheva IP, Houng AK, Reed GL. Decompensated heart failure is associated with reduced Corin levels and decreased cleavage of Pro\u2013Atrial natriuretic peptide. Circ Heart Fail. 2011;4(2):114\u201320. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.895581.","journal-title":"Circ Heart Fail"},{"key":"732_CR20","doi-asserted-by":"publisher","first-page":"1164524","DOI":"10.3389\/fcvm.2023.1164524","volume":"10","author":"Y Niu","year":"2023","unstructured":"Niu Y, Zhou T, Zhang S, et al. Corin deficiency impairs cardiac function in mouse models of heart failure. Front Cardiovasc Med. 2023;10:1164524. https:\/\/doi.org\/10.3389\/fcvm.2023.1164524.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"732_CR21","doi-asserted-by":"publisher","first-page":"R639","DOI":"10.1152\/ajpregu.00074.2015","volume":"309","author":"T Nishikimi","year":"2015","unstructured":"Nishikimi T, Nakagawa Y, Minamino N, et al. Pro-B-type natriuretic peptide is cleaved intracellularly: impact of distance between O -glycosylation and cleavage sites. Am J Physiol Regul Integr Comp Physiol. 2015;309(6):R639\u201349. https:\/\/doi.org\/10.1152\/ajpregu.00074.2015.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"732_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13036-017-0093-0","volume":"12","author":"S Fu","year":"2018","unstructured":"Fu S, Ping P, Wang F, Luo L. Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure. J Biol Eng. 2018;12(1):2. https:\/\/doi.org\/10.1186\/s13036-017-0093-0.","journal-title":"J Biol Eng"},{"issue":"10","key":"732_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101746","volume":"8","author":"C Lugnier","year":"2019","unstructured":"Lugnier C, Meyer A, Charloux A, Andr\u00e8s E, G\u00e9ny B, Talha S. The endocrine function of the heart: physiology and involvements of natriuretic peptides and cyclic nucleotide phosphodiesterases in heart failure. J Clin Med. 2019;8(10):1746. https:\/\/doi.org\/10.3390\/jcm8101746.","journal-title":"J Clin Med"},{"key":"732_CR24","doi-asserted-by":"publisher","first-page":"673497","DOI":"10.3389\/fphys.2021.673497","volume":"12","author":"EE Khoury","year":"2021","unstructured":"Khoury EE, Fokra A, Kinaneh S, Knaney Y, Aronson D, Abassi Z. Distribution of cardiac and renal Corin and proprotein convertase Subtilisin\/Kexin-6 in the experimental model of Cardio-Renal syndrome of various severities. Front Physiol. 2021;12:673497. https:\/\/doi.org\/10.3389\/fphys.2021.673497.","journal-title":"Front Physiol"},{"key":"732_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-407680-8.00001-4","volume":"62","author":"T Ichiki","year":"2013","unstructured":"Ichiki T, Huntley BK, Burnett JC. BNP molecular forms and processing by the cardiac Serine protease Corin. Advances in clinical chemistry Elsevier. 2013;62:1\u201331. https:\/\/doi.org\/10.1016\/B978-0-12-407680-8.00001-4.","journal-title":"Advances in clinical chemistry. Elsevier"},{"issue":"1","key":"732_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/CIRCHEARTFAILURE.114.001174","volume":"8","author":"BK Huntley","year":"2015","unstructured":"Huntley BK, Sandberg SM, Heublein DM, Sangaralingham SJ, Burnett JC, Ichiki T. Pro\u2013B-type natriuretic peptide-1-108 processing and degradation in human heart failure. Circ Heart Fail. 2015;8(1):89\u201397. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001174.","journal-title":"Circ Heart Fail"},{"key":"732_CR27","doi-asserted-by":"publisher","DOI":"10.21037\/jlpm.2017.05.08","volume":"2","author":"NI Yang","year":"2017","unstructured":"Yang NI, Wang CH. The emerging value of molecular forms of B-type natriuretic peptide in heart failure. J Lab Precis Med. 2017;2:23. https:\/\/doi.org\/10.21037\/jlpm.2017.05.08.","journal-title":"J Lab Precis Med"},{"issue":"5","key":"732_CR28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1161\/CIRCRESAHA.108.177352","volume":"103","author":"W Wang","year":"2008","unstructured":"Wang W, Liao X, Fukuda K, et al. Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity. Circ Res. 2008;103(5):502\u20138. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.177352.","journal-title":"Circ Res"},{"issue":"2","key":"732_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.111.960948","volume":"4","author":"DL Dries","year":"2011","unstructured":"Dries DL. Process matters: emerging concepts underlying impaired natriuretic peptide system function in heart failure. Circ Heart Fail. 2011;4(2):107\u201310. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.111.960948.","journal-title":"Circ Heart Fail"},{"key":"732_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.legalmed.2021.102006","volume":"55","author":"G Yamasaki","year":"2022","unstructured":"Yamasaki G, Sakurada M, Kitagawa K, Kondo T, Takahashi M, Ueno Y. Effect of FURIN SNP rs17514846 on coronary atherosclerosis in human cardiac specimens: an autopsy study of 106 cases. Leg Med. 2022;55:102006. https:\/\/doi.org\/10.1016\/j.legalmed.2021.102006.","journal-title":"Leg Med"},{"issue":"6","key":"732_CR31","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001104","volume":"3","author":"R Lee","year":"2014","unstructured":"Lee R, Xu B, Rame JE, Felkin LE, Barton P, Dries DL. Regulated inositol-requiring protein 1\u2010dependent decay as a mechanism of corin RNA and protein deficiency in advanced human systolic heart failure. J Am Heart Assoc. 2014;3(6):e001104. https:\/\/doi.org\/10.1161\/JAHA.114.001104.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"732_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1161\/HYPERTENSIONAHA.115.06300","volume":"67","author":"R Tripathi","year":"2016","unstructured":"Tripathi R, Wang D, Sullivan R, Fan THM, Gladysheva IP, Reed GL. Depressed corin levels indicate early systolic dysfunction before increases of atrial natriuretic peptide\/B-Type natriuretic peptide and heart failure development. Hypertension. 2016;67(2):362\u20137. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06300.","journal-title":"Hypertension"},{"issue":"8","key":"732_CR33","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1111\/jcmm.16310","volume":"25","author":"EE Khoury","year":"2021","unstructured":"Khoury EE, Knaney Y, Fokra A, et al. <article-title update=\"added\">Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: potential implication for COVID\u201019 disease. J Cell Mol Med. 2021;25(8):3840\u201355. https:\/\/doi.org\/10.1111\/jcmm.16310.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"732_CR34","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12872-021-02029-y","volume":"21","author":"ZW Liu","year":"2021","unstructured":"Liu ZW, Ma Q, Liu J, Li JW, Chen YD. The association between plasma Furin and cardiovascular events after acute myocardial infarction. BMC Cardiovasc Disord. 2021;21(1):468. https:\/\/doi.org\/10.1186\/s12872-021-02029-y.","journal-title":"BMC Cardiovasc Disord"},{"issue":"8","key":"732_CR35","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cardfail.2010.03.010","volume":"16","author":"K Shrestha","year":"2010","unstructured":"Shrestha K, Troughton RW, Borowski AG, et al. Plasma Corin levels provide minimal prognostic utility incremental to natriuretic peptides in chronic systolic heart failure. J Card Fail. 2010;16(8):621\u20137. https:\/\/doi.org\/10.1016\/j.cardfail.2010.03.010.","journal-title":"J Card Fail"},{"issue":"9","key":"732_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202571","volume":"13","author":"D Wang","year":"2018","unstructured":"Wang D, Gladysheva IP, Sullivan RD, et al. Increases in plasma corin levels following experimental myocardial infarction reflect the severity of ischemic injury. PLoS One. 2018;13(9):e0202571. https:\/\/doi.org\/10.1371\/journal.pone.0202571.","journal-title":"PLoS One"},{"issue":"3","key":"732_CR37","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1021\/acsptsci.3c00325","volume":"7","author":"S Wichaiyo","year":"2024","unstructured":"Wichaiyo S, Koonyosying P, Morales NP. Functional roles of Furin in cardio-cerebrovascular diseases. ACS Pharmacol Transl Sci. 2024;7(3):570\u201385. https:\/\/doi.org\/10.1021\/acsptsci.3c00325.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"8","key":"732_CR38","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jchf.2016.03.006","volume":"4","author":"X Zhou","year":"2016","unstructured":"Zhou X, Chen JC, Liu Y, et al. Plasma Corin as a predictor of cardiovascular events in patients with chronic heart failure. JACC Heart Fail. 2016;4(8):664\u20139. https:\/\/doi.org\/10.1016\/j.jchf.2016.03.006.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"732_CR39","doi-asserted-by":"publisher","first-page":"19848","DOI":"10.1038\/s41598-024-70587-0","volume":"14","author":"CE Chen","year":"2024","unstructured":"Chen CE, Guo JY, Chou RH, et al. Circulating Corin concentration is associated with risk of mortality and acute kidney injury in critically ill patients. Sci Rep. 2024;14(1):19848. https:\/\/doi.org\/10.1038\/s41598-024-70587-0.","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"732_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cca.2009.09.004","volume":"409","author":"A Peleg","year":"2009","unstructured":"Peleg A, Jaffe AS, Hasin Y. Enzyme-linked Immunoabsorbent assay for detection of human Serine protease Corin in blood. Clin Chim Acta. 2009;409(1\u20132):85\u20139. https:\/\/doi.org\/10.1016\/j.cca.2009.09.004.","journal-title":"Clin Chim Acta"},{"issue":"6\u20137","key":"732_CR41","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3109\/1354750X.2015.1093032","volume":"20","author":"SA Fathy","year":"2015","unstructured":"Fathy SA, Abdel Hamid FF, Zabut BM, Jamee AF, Ali MAM, Abu Mustafa AM. Diagnostic utility of BNP, Corin and Furin as biomarkers for cardiovascular complications in type 2 diabetes mellitus patients. Biomarkers. 2015;20(6\u20137):460\u20139. https:\/\/doi.org\/10.3109\/1354750X.2015.1093032.","journal-title":"Biomarkers"},{"issue":"13","key":"732_CR42","doi-asserted-by":"publisher","first-page":"e033544","DOI":"10.1161\/JAHA.123.033544","volume":"13","author":"NL Patel-Murray","year":"2024","unstructured":"Patel-Murray NL, Zhang L, Claggett BL, et al. Aptamer proteomics for biomarker discovery in heart failure with preserved ejection fraction: the PARAGON\u2010HF proteomic substudy. J Am Heart Assoc. 2024;13(13):e033544. https:\/\/doi.org\/10.1161\/JAHA.123.033544.","journal-title":"J Am Heart Assoc"},{"key":"732_CR43","unstructured":"Update | Cardiac Biomarkers and Heart Failure. American College of Cardiology. Accessed 22 July 2025. https:\/\/www.acc.org\/Latest-in-Cardiology\/Articles\/2015\/02\/09\/13\/00\/http%3a%2f%2fwww.acc.org%2fLatest-in-Cardiology%2fArticles%2f2015%2f02%2f09%2f13%2f00%2fCardiac-Biomarkers-and-Heart-Failure"},{"issue":"5","key":"732_CR44","doi-asserted-by":"publisher","first-page":"570","DOI":"10.4103\/0366-6999.177000","volume":"129","author":"DH Huang","year":"2016","unstructured":"Huang DH, Sun H, Shi JP. Diagnostic value of soluble suppression of Tumorigenicity-2 for heart failure. Chin Med J (Engl). 2016;129(5):570\u20137. https:\/\/doi.org\/10.4103\/0366-6999.177000.","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"732_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019961","volume":"10","author":"Y Niu","year":"2021","unstructured":"Niu Y, Zhang S, Gu X, et al. Recombinant soluble Corin improves cardiac function in mouse models of heart failure. J Am Heart Assoc. 2021;10(7):e019961. https:\/\/doi.org\/10.1161\/JAHA.120.019961.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"732_CR46","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1038\/s41598-024-56025-1","volume":"14","author":"C Frisk","year":"2024","unstructured":"Frisk C, Das S, Eriksson MJ, et al. Cardiac biopsies reveal differences in transcriptomics between left and right ventricle in patients with or without diagnostic signs of heart failure. Sci Rep. 2024;14(1):5811. https:\/\/doi.org\/10.1038\/s41598-024-56025-1.","journal-title":"Sci Rep"},{"key":"732_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cbi.2015.09.025","volume":"242","author":"T Luo","year":"2015","unstructured":"Luo T, Chen B, Wang X. 4-PBA prevents pressure overload-induced myocardial hypertrophy and interstitial fibrosis by attenuating endoplasmic reticulum stress. Chem Biol Interact. 2015;242:99\u2013106. https:\/\/doi.org\/10.1016\/j.cbi.2015.09.025.","journal-title":"Chem Biol Interact"},{"issue":"9","key":"732_CR48","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0735-1097(02)01797-7","volume":"39","author":"J Sochman","year":"2002","unstructured":"Sochman J. N-acetylcysteine in acute cardiology: 10 years later. J Am Coll Cardiol. 2002;39(9):1422\u20138. https:\/\/doi.org\/10.1016\/S0735-1097(02)01797-7.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"732_CR49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4330\/wjc.v10.i9.74","volume":"10","author":"J Gonz\u00e1lez-Montero","year":"2018","unstructured":"Gonz\u00e1lez-Montero J, Brito R, Gajardo AI, Rodrigo R. Myocardial reperfusion injury and oxidative stress: therapeutic opportunities. World J Cardiol. 2018;10(9):74\u201386. https:\/\/doi.org\/10.4330\/wjc.v10.i9.74.","journal-title":"World J Cardiol"},{"issue":"9","key":"732_CR50","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/nm.3920","volume":"21","author":"S Chen","year":"2015","unstructured":"Chen S, Cao P, Dong N, et al. PCSK6-mediated Corin activation is essential for normal blood pressure. Nat Med. 2015;21(9):1048\u201353. https:\/\/doi.org\/10.1038\/nm.3920.","journal-title":"Nat Med"},{"issue":"6","key":"732_CR51","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1161\/CIRCHEARTFAILURE.109.866822","volume":"2","author":"JE Rame","year":"2009","unstructured":"Rame JE, Tam SW, McNamara D, et al. Dysfunctional Corin I555(P568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure Substudy. Circ Heart Fail. 2009;2(6):541\u20138. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.866822.","journal-title":"Circ Heart Fail"},{"issue":"5","key":"732_CR52","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1161\/HYPERTENSIONAHA.112.201244","volume":"60","author":"W Wang","year":"2012","unstructured":"Wang W, Cui Y, Shen J, et al. Salt-sensitive hypertension and cardiac hypertrophy in transgenic mice expressing a corin variant identified in blacks. Hypertension. 2012;60(5):1352\u20138. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.201244.","journal-title":"Hypertension"},{"issue":"2","key":"732_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jchf.2020.08.015","volume":"9","author":"DHF Gommans","year":"2021","unstructured":"Gommans DHF, Revuelta-Lopez E, Lupon J, et al. Soluble neprilysin and corin concentrations in relation to clinical outcome in chronic heart failure. JACC: Heart Failure. 2021;9(2):85\u201395. https:\/\/doi.org\/10.1016\/j.jchf.2020.08.015.","journal-title":"JACC: Heart Failure"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-025-00732-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11897-025-00732-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-025-00732-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:26:15Z","timestamp":1768544775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11897-025-00732-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1007\/s11897-025-00732-x","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable (review article).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable (no human\/animal data).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent to Participate\/Publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}